Edition:
United Kingdom

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

536.70INR
19 Jul 2019
Change (% chg)

Rs-10.30 (-1.88%)
Prev Close
Rs547.00
Open
Rs550.80
Day's High
Rs552.00
Day's Low
Rs535.50
Volume
783,708
Avg. Vol
2,079,626
52-wk High
Rs678.45
52-wk Low
Rs483.75

About

Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered... (more)

Overall

Beta: 0.47
Market Cap(Mil.): Rs471,067.19
Shares Outstanding(Mil.): 804.69
Dividend: 2.00
Yield (%): 0.34

Financials

  CIPL.NS Industry Sector
P/E (TTM): 43.76 29.88 32.66
EPS (TTM): 13.38 -- --
ROI: -- 14.90 14.49
ROE: -- 16.02 15.79

UPDATE 1-India's Cipla Q3 profit falls as lean India sales, tax cost weigh

Feb 6 Cipla Ltd, India's second-largest generic drugmaker by market capitalisation, reported on Wednesday a 17.1 percent drop in quarterly profit, dragged down by higher tax expenses and weak sales in domestic market.

06 Feb 2019

India's Cipla Q3 profit falls, lags estimate

Feb 6 Cipla Ltd, India's second-biggest generic drugmaker by market capitalisation, reported a 17.1 percent fall in third-quarter profit on Wednesday, hurt by higher tax expenses.

06 Feb 2019

Earnings vs. Estimates